Metastasis Research Network (U54 Clinical Trial Not Allowed)
This grant funds multidisciplinary research centers to study the complex, system-level processes of cancer metastasis across all cancer types, aiming for a deeper, integrated understanding of how metastasis occurs and responds to therapies.
Funder: National Institutes of Health (NIH)
Due Dates: May 15, 2026 (Forecasted)
Funding Amounts: Up to $1,700,000 per award; approximately $6,800,000 total program funding; 4 awards expected; project duration not specified.
Summary: Supports multidisciplinary research centers to advance systems-level understanding of cancer metastasis through integrative, mechanistic studies.
Key Information: No clinical trials allowed; forecasted opportunity—dates subject to change.
Description
This funding opportunity, issued by the National Cancer Institute (NCI), seeks applications for U54 Specialized Centers as part of the Metastasis Research Network (MetNet). The goal is to promote a comprehensive, systems-level understanding of cancer metastasis. Funded centers will serve as collaborative hubs, each organized around a central scientific theme and supported by two or three multidisciplinary basic research projects. These projects should employ integrative, mechanistic approaches to unravel the complex, dynamic, and emergent processes underlying metastasis. Themes may include, but are not limited to, early dissemination, tumor microenvironment interactions, dormancy, or therapeutic responses. All cancer types, including rare and pediatric metastatic cancers, are eligible for study. No clinical trials are permitted under this opportunity.
